fluconazole and piperazine

fluconazole has been researched along with piperazine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Battini, N; Hu, YY; Yadav Bheemanaboina, RR; Zhou, CH	1

Other Studies

2 other study(ies) available for fluconazole and piperazine

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Sulfonamide-Derived Four-Component Molecular Hybrids as Novel DNA-Targeting Membrane Active Potentiators against Clinical Escherichia coli. Molecular pharmaceutics, 2019, 03-04, Volume: 16, Issue:3 Topics: Anti-Bacterial Agents; Antifungal Agents; Azoles; Carbonic Anhydrases; Cell Membrane Permeability; Cell Survival; DNA, Bacterial; Drug Compounding; Drug Resistance, Bacterial; Drug Resistance, Fungal; Drug Therapy, Combination; Escherichia coli; Ethanol; Fluconazole; Humans; Hydrogen Bonding; Isoenzymes; MCF-7 Cells; Metronidazole; Models, Molecular; Molecular Docking Simulation; Norfloxacin; Piperazine; Sulfonamides	2019

Article

Year

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

Chemical research in toxicology, 2010, Volume: 23, Issue:1

Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010

Sulfonamide-Derived Four-Component Molecular Hybrids as Novel DNA-Targeting Membrane Active Potentiators against Clinical Escherichia coli.

Molecular pharmaceutics, 2019, 03-04, Volume: 16, Issue:3

Topics: Anti-Bacterial Agents; Antifungal Agents; Azoles; Carbonic Anhydrases; Cell Membrane Permeability; Cell Survival; DNA, Bacterial; Drug Compounding; Drug Resistance, Bacterial; Drug Resistance, Fungal; Drug Therapy, Combination; Escherichia coli; Ethanol; Fluconazole; Humans; Hydrogen Bonding; Isoenzymes; MCF-7 Cells; Metronidazole; Models, Molecular; Molecular Docking Simulation; Norfloxacin; Piperazine; Sulfonamides

2019